Bezafibrate is an agonist of peroxisome proliferator-activated receptor alpha (PPARalpha) with antilipidemic activity. Bezafibrate is a fibrate drug used for the treatment of hyperlipidaemia. Bezafibrate decreases triglyceride levels, increases high density lipoprotein cholesterol levels, and decreases total and low density lipoprotein cholesterol levels. It is commonly marketed as Bezalip.
Properties:
Appearance & Physical State: solid
Density: 1.26 g/cm3
Melting Point: 184ºC
Boiling Point: 572.1ºC at 760 mmHg
Flash Point: 299.8ºC
Refractive Index: 1.583
PPAR Inhibitors Related Prodcuts:
GW9662; GSK3787; Fenofibric acid